CSIMarket Company Name, Ticker, Suppliers, else..


Intellia Therapeutics Inc   (NTLA)
Other Ticker:  
 

Intellia Therapeutics Inc

NTLA's Fundamental analysis



Intellia Therapeutics Inc 's sales fell by -24.02 % in III. Quarter 2024 from the same quarter a year ago. Ranking at No. 1740

In Vitro & In Vivo Diagnostic Substances industry recorded growth of revenues by 5.7 %

Intellia Therapeutics Inc net loss increased from $-122 millions, to $-136 millions in III. Quarter 2024,

• More on NTLA's Growth


Intellia Therapeutics Inc
realized a net loss in trailing twelve months.

Intellia Therapeutics Inc realized cash reduction of $ -0.46 per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 33.06.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 7.68.


• More on NTLA's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 1.91
 Tangible Book Value (Per Share $) 9.53

Intellia Therapeutics Inc
realized net loss in trailing twelve months.

Intellia Therapeutics Inc realized cash outflow of $ -0.46per share in trailing twelve-month period.
In Vitro & In Vivo Diagnostic Substances industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 33.06.
In Vitro & In Vivo Diagnostic Substances industry's Price to Sales ratio is at 7.68.

Intellia Therapeutics Inc Price to Book Ratio is at 1.55 lower than Industry Avg. of 528.04. and higher than S&P 500 Avg. of 0.01

• More on NTLA's Valuation

•  Market Capitalization (Millions $) 1,488
•  Shares Outstanding (Millions) 101
•  Employees -
•  Revenues (TTM) (Millions $) 45
•  Net Income (TTM) (Millions $) -522
•  Cash Flow (TTM) (Millions $) -47
•  Capital Exp. (TTM) (Millions $) -6
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) 1.91
•  Tangible Book Value (Per Share $) 9.53

•  Market Capitalization (Millions $) 1,488
•  Shares Outstanding (Millions) 101
•  Employees -
•  Revenues (TTM) (Millions $) 45
•  Net Income (TTM) (Millions $) -522
•  Cash Flow (TTM) (Millions $) -47
•  Capital Exp. (TTM) (Millions $) -6





  Ratio
•   Capital Ratio (MRQ) 6.73
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 0.22
•  Asset Turnover Ratio (TTM) 0.04
•  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com